This study was designed to investigate whether the type of specimen biopsy vs. Prognostic effect of activated egfr expression in human colon. Tumors with a reference egfr immunohistochemistry score clearly below or above the cutoff egfr immunohistochemistry score around the cutoff. Egfr protein expression in nonsmall cell lung cancer predicts. Jun 20, 2012 immunohistochemical ihc assays performed on formalinfixed paraffinembedded ffpe tissue sections traditionally have been semiquantified by pathologist visual scoring of staining. This score is for general health information only, and is not to be used as a substitute for medical advice, diagnosis, or treatment of any health condition or problem. Dec 18, 2010 immunohistochemistry ihc with mutationspecific antibodies may be an ancillary method of detecting egfr mutations in lung cancer patients. Comparison of different scoring systems for immunohistochemical staining. Many researchers have attempted subclassification of tnbcs using a panel of surrogate immunohistochemical ihc markers against basal cks and epidermal growth factor receptor egfr for identification of blbc subtype. Quantitative comparison of immunohistochemical staining. Reproducibility of the egfr immunohistochemistry scores.
There are two methods for ihc scoring 1 automated software based and 2 manual method. Immunohistochemistry of antiepidermal growth factor receptor. Detection of egfr mutations with mutationspecific antibodies. Comparison of different scoring systems for immunohistochemical staining article pdf available in journal of clinical pathology 521. The human epidermal growth factor receptor 2 gene erbb2 her2 is amplified and its protein is overexpressed in many cancer types. Assessment of a her2 scoring system for colorectal cancer. Evidence suggests that epidermal growth factor receptor egfr activation status may better predict the clinical behaviour of colon cancers than does egfr expression. Correlation of egfr expression, gene copy number and. Invitrogens monoclonal mouse antiepidermal growth factor receptor egfr antibody is intended to qualitatively stain squamous cell carcinoma in frozen and formalinfixed, paraffinembedded tissue sections. Scoring of egfr immunohistochemistry download table. Anti egfr antibodies are offered by a number of suppliers. Ihc analysis of egfr mutations in five human nsclc cell openi. Identification of egfr mutations by immunohistochemistry.
Research studies demonstrate that expanding this ihc panel to include markers of basal breast cancers, such as cytokeratin 56 ck56 and epidermal growth factor receptor 1 egfr or her1, can enable more detailed molecular subtyping, approximating taxonomies based on molecular profiling 1, 8, 9. Epidermal growth factor receptor egfr h11 is a mouse monoclonal antibody that is intended for laboratory use in the qualitative identification of egfr protein by immunohistochemistry ihc in formalinfixed paraffinembedded ffpe human tissues. We developed this toolbox using a semiautomatic scheme that is suitable for different kinds of ihc image analysis. Egfr pharmdx specifically detects the egfr her1 protein in egfr expressing cells. Epidermal growth factor receptor immunohistochemistry image. We aimed to identify the discriminating capacity of immunohistochemical ihc scoring to detect l858r and e746a750 deletion mutation in lung adenocarcinoma patients. Egfr immunohistochemistry scoring system in nsclc according to the discriminating threshold score of 200, an international round robin test rrt was initiated. The sensitivity and specificity of immunohistochemistry ihc was compared with the standard polymerase chain reaction pcrbased method for detecting common activating epidermal growth factor receptor egfr mutations in nonsmallcell lung cancer nsclc. The first scoring system was originally proposed by fisher and modified by adams fisher et al. Proteins serve many functions in organisms including transport of molecules, structure, cell adhesion and as. We thank all members of the institutes participating in the open egfr ihc lung scc trial for providing feedback and information on technical details of their egfr analysis. Inhibition of both egfr and met sensitized hcc cells to parpi, and both egfr and met are known to be overexpressed in hcc.
Mutationspecific antibodies have recently been developed for identification of epidermal growth factor receptor egfr mutations by immunohistochemistry ihc. The lack of an agreed reproducible scoring criteria for epidermal growth factor receptor immunohistochemistry has, in various clinical trials yielded conflicting results as to the use of epidermal. Detection of tki resistance mutations such as t790m in patients being treated with a tki is useful for planning alternate treatment. This study was designed to optimize the ihc protocol and the criteria for interpretation of the results using dna sequencing as the gold. Epidermal growth factor receptor egfr overexpression can occur in a variety of tumor types, including breast, prostate, ovarian, brain, lung and predominantly squamous cell carcinomas.
In conclusion, total egfr expression should be included in the ihc interpretation of. Epidermal growth factor receptor egfr mutationspecific immunohistochemistry ihc provides benefits in poorly preserved or degraded tumour tissue. Egfr antibody staining protocol for immunohistochemistry. Egfr, her2 and her3 dimerization patterns guide targeted. Patient samples that show alk ihc positivity are subsequently subjected to alk fish analysis for confirmation of a positive alk status 1.
The epidermal growth factor receptor egfr, her1, cerbb1 is a 170 kda transmembrane protein consisting of an extracellular egfbinding domain, a short transmembrane region, and an intracellular domain with ligandactivated tyrosine kinase activity. Immunohistochemical detection of mutations in the epidermal. A comparison of egfr mutation testing methods in lung. As inherent from the diagnostic ihc scoring system for her2, 31, 42 intratumoral heterogeneity of membranous her2 expression was also seen in our group of eacs supporting information fig. If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. This report provides an explanation for the poor efficacy of parpi against hcc and suggests combinatorial treatment consisting of egfr, met, and parp inhibitors may be an effective therapeutic strategy in hcc. An immunohistochemical study of egfr expression in. Egfr ihc score for selection of cetuximab treatment. Interpretation must be made within the context of the patients clinical history and other diagnostic tests by a qualified pathologist. Prognostic significance of egfr, muc1 and pdl1 expressions. This scoring system is shown in table 1 and represents the combination. Egfr mutation analysis is recommended in nonsmall cell lung carcinoma nsclc to detect mutations commonly l858r and exon 19 deletions associated with increased sensitivity to egfr tyrosine kinase inhibitors. Especially, the score evaluating the probability of egfr mutation does not substitute for egfr genotyping.
Including total egfr staining in scoring improves egfr. Performance of automated scoring of er, pr, her2, ck56. The objective of this study is to compare two egfr testing methodologies a commercial realtime pcr kit and a specific egfr mutant immunohistochemistry, with direct sequencing and to investigate the limit of detection lod of both pcrbased methods. Performance of automated scoring of er, pr, her2, ck56 and. Tumors with egfr mutations showed good response to egfr tyrosine kinase inhibitors tkis. Expression profiles of her2, egfr, met and fgfr2 in a large. Prognostic implications of immunohistochemistry markers for egfr. Re scoring of egfr ihc status in saturn by hscore with the magnification rule found that erlotinib provided similar benefits in terms of pfs or os for subsets with high or low egfr expression, in the overall and egfr wt populations. Immunohistochemistry is a technique used to determine the presence and level of specific cellular proteins. When using ihc, the median hscores for the membranous egfr. Epidermal growth factor receptor egfr is a novel target for therapy in subsets of nonsmall cell lung cancer, especially adenocarcinoma. Assessment of epidermal growth factor receptor egfr signaling in.
The automated though faster has many inherent problems and personally i. Egfr protein expression determined by ihc with dako pharmdx kit. Epidermal growth factor receptor immunohistochemistry. Egfr ihc kit features the egfr antibody clone 31g7, which is an industry standard for the detection of egfr in formalinfixed, paraffinembedded tissue samples. This target gene encodes the protein epidermal growth factor receptor in humans and may also be known as egfra, erbb, erbb1, her1, avian erythroblastic leukemia viral verbb oncogene homolog, and nisbd2. Epidermal growth factor receptor immunohistochemistry image analysis in advanced colorectal cancer. Egfr mutation status was analyzed by dna assays, and compared with ihc results in five nonsmallcell lung cancer nsclc cell lines and tumor samples from 78 stage iv nsclc patients. Egfr mutationspecific ihc provides benefits in patients requiring a rapid determination. Egfr e746a750 deletion specific 6b6 antibody stained h1650 and pc9 harboring the exon 19 deletion, and egfr l858r mutantspecific 43b2 antibody stained the h1975 cell line with exon 21 mutation. Egfr immunohistochemistry as biomarker for antibodybased. Egfr ihc was scored independently by three observers oc, js, and.
Identification of egfr mutations by immunohistochemistry with. Egfr gene copy number assessment from areas with highest egfr. Epidermal growth factor receptor egfr antibody staining protocol for immunohistochemistry. Download table scoring of egfr immunohistochemistry from publication. Egfr immunoreactivity was evaluated in 46 crcs without regional lymph node involvement as control group and 46 crcs with regional lymph node metastasis as case group and the following results were observed. Reproducibility of immunohistochemical scoring for. Immunohistochemical analyses and scoring immunohistochemical ihc method was used to detect the expression of muc1, egfr and pdl1. The discovery of activating epidermal growth factor receptor egfr mutations and the anaplastic lymphoma kinase gene rearrangement led to significantly improved outcomes with egfrtyrosine kinase inhibitors tkis and crizotinib, respectively.
Evaluation of egfr protein expression by immunohistochemistry. Ihc correctly identified del 19 in the h1650 and pc9 cell lines, l858r. Immunohistochemical detection of egfr in paraffinembedded tumor tissues. Tumors that express egfr are associated with a poor prognosis and a shorter diseasefree survival. Ihc was performed on 5mm sections of formalinfixed, paraffinembedded tissues. Immunohistochemical staining with egfr mutationspecific antibodies.
Proteins are polymers made up of strings of amino acids. To determine the alk status in nonsmallcell lung cancer nsclc, a validated alk ihc test is used as a first screening method. Mouse antiepidermal growth factor receptor egfr clone. The lack of an agreed reproducible scoring criteria for epidermal growth factor receptor immunohistochemistry has, in various clinical trials yielded conflicting. Immunohistochemistry for egfr mutation detection in nonsmall. Monoclonal antibody pdl1 e1l3n,cell signaling,usa was used to detect pdl1, anti egfr ab320077, abcam, usa and. Ihc analysis of egfr mutations in five human nsclc cell lines.
Your doctor uses your blood test results, plus your age, size, gender and ethnic group to calculate how many millilitres of waste your kidneys should be able to filter in a minute. The egfr pharmdxtm assay is a qualitative immunohistochemical ihc kit system to. The test measures the levels of a waste product called creatinine in your blood. The epidermal growth factor receptor egfr plays a role in multiple tumor cell. A549 and h460 showed negativity for both mutationspecific antibodies. An initial analysis for ck56 and egfr in the entire tma dataset resulted in very poor performance of automated scoring compared with visual scores by rater 1 or rater 2 data not shown. Ihc is useful for validating biomarkers discovered through genomics methods as large clinical repositories of ffpe specimens support the construction of tissue microarrays tmas for high throughput studies. According to the scoring method, the ihc method is useful to predict the. We aimed to identify the discriminating capacity of immunohistochemical ihc scoring to detect l858r and e746a750 deletion mutation in lung adenocarcinoma patients and predict egfr tkis response. Comparison of diverent scoring systems for immunohistochemical staining e j adams, j a green, a h clark, j h youngson abstract aimto carry out an objective assessment of two systems of scoring immuno. Epidermal growth factor receptor egfr is overexpressed in 60% of nonsmall cell lung cancer nsclc cases. Mar 14, 2014 the protein expressions of her2, egfr, met and fgfr2 were evaluated using immunohistochemistry, and the gene amplifications of her2, egfr and met were examined using dualcolor in situ hybridization. Variation in staining intensity due to choice of fixative and storage time of tissue sections. Egfr and cmet cooperate to enhance resistance to parp.
1236 1266 584 235 278 783 785 320 504 1381 448 1391 382 1006 1518 247 1222 625 916 1525 363 347 1084 895 98 1370 1173 412 1078 926 618 638 995 582 337 1171 1106